(redirected from Advanced Gastric Cancer)
Also found in: Medical.
Category filter:
AGCAutomatic Gain Control
AGCAutomotive Glass Cartridge (fuse)
AGCAutomatic Gain Control (US DoD)
AGCAssociated General Contractors
AGCAssociated General Contractors of America
AGCApollo Guidance Computer (NASA)
AGCAttorney-General's Chambers (Singapore)
AGCAmerican Game Cartridges (Chandler, AZ)
AGCAshanti Goldfields Company (Ghana)
AGCAustralian Girls Choir (est. 1984)
AGCAutomatic Generation Control (electric utilities; power systems)
AGCArmy Geospatial Center (USACE)
AGCAssociate General Counsel
AGCAutomatic Generation Control
AGCAdaptive Gain Control
AGCAdvanced Ground Contact
AGCAtypical Glandular Cells
AGCAspartate/Glutamate Carrier
AGCAllegheny County Airport (airport code, Pittsburgh, PA )
AGCAsahi Glass Company
AGCAmador Gold Corp. (Canada)
AGCAdvanced Gastric Cancer
AGCAnnual Giving Campaign (various organizations)
AGCAdjutant General's Corps
AGCArt Glass Ceramic
AGCAutomatic Gauge Control (steel industry)
AGCAggressive Content (behavioral health)
AGCAbsolute Granulocyte Count
AGCAttorney Grievance Commission
AGCAmerican General Corporation
AGCAssociation of Graphic Communications
AGCAssociation of Global Custodians (bank group)
AGCArkansas Geological Commission
AGCAmerican Greyhound Council
AGCAccelerated Global Connections (networking)
AGCAdjustable Gain Control (less common)
AGCAsia Global Crossing Ltd.
AGCAssociated Gospel Churches
AGCAlternative Grand Campaign (gaming)
AGCAcademic Governing Council (various organizations)
AGCAutomatic Guided Cart (material handling)
AGCAerojet General Corporation
AGCAgricultural Genetics Company (UK)
AGCAdvanced Graduate Certificate
AGCAusclad Group of Companies (Perth, Australia)
AGCAdult Gaming Centre (UK)
AGCAgriculture Canada
AGCAir-Ground Communications
AGCAustralian Gold Council
AGCAsian Greek Council
AGCGeneral Communications Vessel (US Navy)
AGCAt a Glance Chapter
AGCAssociation Généalogique de la Charente (French: Charente Genealogical Association; Cherente, France)
AGCAvid Gaming Community
AGCAdvantest Green Corporation (Japan)
AGCAfrican Ground Council
AGCAtlantic Gulf Communities
AGCArea Generation Control (electric utility)
AGCAdvanced Gas Centrifuge
AGCAgent Based Grid Computing
AGCChief Aerographer's Mate (Naval rating)
AGCAmphibious Group Command
AGCArmy General Counsel
AGCAntenna Gain Control
AGCAir Ground Co-Operative ATS (Air Traffic Services)
AGCAsociación Guatemalteca de Cardiología (Guatemala)
AGCAdaptive Gaussian Classifier
AGCAttack Group Commander
AGCAgreed Cost of Repairs
AGCAccess Gateway Controller
AGCAudiographics Conferencing
AGCAdvanced Graduate Certification
AGCAtari Games Corp.
AGCAnala Goat Company (Beasley, Texas)
AGCAlgebraic-Geometric Code
AGCActive Test Set Generator and Comparator
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
The addition of trastuzumab to chemotherapy is standard of care for patients with HER2/neu-positive advanced gastric cancer.
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.
Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer. Cancer Chemother Pharmacol 2015; 76: 731-7.
Advanced gastric cancer is difficult to resect, and long-term survival is very poor.[15] Unfortunately, more than 80% of Chinese patients are diagnosed at advanced stages.[6] Therefore, patients with advanced gastric cancer may be advised to consider treatment that combines chemotherapy, radiotherapy, and surgery.[16] Notably, neoadjuvant chemotherapy significantly increases the R0 resection rate [17] and does not influence perioperative outcomes.[18] Therefore, neoadjuvant chemotherapy is frequently used to downstage tumors and to increase the resection rate.[19],[20]
The expected overall survival for advanced gastric cancer patients who have failed previous chemotherapy and do not receive second-line therapy is approximately 4.0 months.
A recent study shows that retrieving more than 25 lymph-nodes during curative-intent gastrectomy substantially improved survival of advanced gastric cancer without compromising patient safety [11].
There is no previous study on serum TFF3 as a biomarker in EGC population without advanced gastric cancer (AGC).
Segelov et al., "Management of advanced gastric cancer," Expert Review of Gastroenterology & Hepatology, vol.
We tried to summarize the relevant clinical data about specific immune checkpoints agents and the possible future applications in treatment of advanced gastric cancer.
Grothe et al., "Chemotherapy for advanced gastric cancer," Cochrane Database of Systematic Reviews, vol.
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric cancer (ToGA): a phase3 open-label, randomized controlled trial Lancet 2010; 376(9742): 687-97.
Full browser ?